Cancer survivor needs examined beyond specialized care

Following reports that an 18-year-old student celebrating ’schoolies’ week on Queensland’s Gold Coast has been hospitalised with meningococcal disease, health officials have warned schoolies that the after-effects of drinking or drug-taking could disguise the onset of the disease. Queensland health workers are trying to contact 13 other students who may have had close and

Full Post: Schoolies warned that after-effects of drinking or drug-taking could disguise the start of meningococcal disease

According to the National Cancer Policy Board, it is estimated that by the year 2050 there will be more cancer survivors in the United States than those newly diagnosed with the disease.

That is why researchers at The Cancer Institute of New Jersey (CINJ) are taking a closer look at the specific needs of cancer survivors as they transition from specialty care back to their primary care provider. CINJ is a center of excellence of UMDNJ-Robert Wood Johnson Medical School.

A research study sponsored by the National Cancer Institute, CINJ and the U.S. Department of Defense will look at how breast and prostate cancer survivors view their medical needs as they no longer need to be under the care of an oncologist and go back to their regular family doctor, internist or gynecologist for follow-up care. Breast and prostate cancer survivors were chosen as the focus of this trial, because those groups represent the most common forms of cancer in survivors and screenings such as mammograms or blood work to see if the cancer has returned are often performed in a primary care setting.

Shawna V. Hudson, PhD, director of community research at CINJ and assistant professor of family medicine at UMDNJ-Robert Wood Johnson Medical School, is the lead investigator of the trial: “There have only been a few previous studies on this topic and the cancer survivor population continues to grow; therefore, it is critical to identify patterns of care that are most optimal for this group and to help them communicate their needs to general healthcare providers.”

A selected group of 36 survivors will undergo a 60 to 90 minute phone interview and will be asked a number of questions pertaining to how they view care from their primary care physician in relation to follow-up cancer care. Data from this first phase will then be used to develop a separate, self-conducted survey of 15 to 20 minutes featuring similar, but more specific questions targeted toward 720 survivors. While the entire study is expected to last five years, participants will only take part in their individual interview or questionnaire just one time.

Those who are survivors of breast or prostate cancer and are 30 years of age or older are eligible to take part in the study, although other criteria must be met. The study will recruit patients who were seen at CINJ and the Fox Chase Cancer Center in Philadelphia, as well as the affiliated network of hospitals for both institutions. For more information on how to participate, individuals should call CINJ’s Office of Human Research Services at 732-235-8675.

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, CINJ provides patients with access to treatment options not available at other institutions within the state. CINJ currently enrolls more than 1,000 patients on clinical trials, including approximately 15 percent of all new adult cancer patients and approximately 70 percent of all pediatric cancer patients. Enrollment in clinical trials nationwide is fewer than five percent of all adult cancer patients.


Researchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial, which aims to evaluate a new treatment for solid cancer tumors and non-Hodgkin’s lymphoma (NHL) in combination with a chemotherapy agent called cyclophosphamide. CINJ is a center of excellence of UMDNJ-Robert Wood Johnson Medical School. This trial, sponsored by the National

Full Post: Trial looks at new treatment for solid cancer tumors and non-Hodgkin’s lymphoma

Throughout the world, 10 million breast cancer survivors have a lifetime risk for developing lymphedema, a chronic condition that involves swelling of the limbs and impacts physical and psychosocial health. Second only to the recurrence of cancer, it is the most dreaded effect of breast cancer treatment. In a new study, University of Missouri

Full Post: Overweight or obesity increases lymphedema risk for breast cancer survivors

As the nation’s growing population of breast cancer survivors ages, many patients will likely develop common chronic illnesses like diabetes and heart disease, and they’ll need specialized care to balance those problems with the late effects of cancer therapies they received. They’ll also need screenings and advice about new strategies for preventing recurrences of their

Full Post: Survivorship care after breast cancer, call for more action

Mammography and sonography findings help doctors identify and appropriately treat breast cancer in men, according to a study performed at the University of Texas M.D. Cancer Center in Houston, TX. Image findings from 57 male patients who were diagnosed with breast cancer were reviewed during the study. “The findings show that breast cancer in men

Full Post: Male breast cancer

Men who survived childhood leukemia treatment into adulthood were more likely to have low bone mineral density than other adults their age, putting them at risk of osteoporosis and bone fractures, according to a new study. The study, led by James G. Gurney, Ph.D., of the University of Michigan Comprehensive Cancer Center, found that 24

Full Post: Men who survive childhood leukemia have lower bone mineral density